None of the metabolites adds to the agony mitigating activity. Tapentadol and its metabolites are released exclusively (99%) by methods for the kidneys. The outright breathing space after the intravenous association is 1530 +/ - 177 ml/min. Terminal half-life is all-around 5-6 hours after oral association.